United Therapeutics Corporation Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options (Deprecated 2017-01-31)
United Therapeutics Corporation (UTHR) reported Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options (Deprecated 2017-01-31) of $37.43 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-25.
Discontinued › Notes › Compensation Related Costs
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions · last filed 2016-02-25
- United Therapeutics Corporation employee service share-based compensation, tax benefit realized from exercise of stock options (deprecated 2017-01-31) for fiscal 2015 was $37.43M, a 21.34% increase from fiscal 2014.
- United Therapeutics Corporation employee service share-based compensation, tax benefit realized from exercise of stock options (deprecated 2017-01-31) for fiscal 2014 was $30.84M, a 231.70% increase from fiscal 2013.
- United Therapeutics Corporation employee service share-based compensation, tax benefit realized from exercise of stock options (deprecated 2017-01-31) for fiscal 2013 was $9.30M, a 204.49% increase from fiscal 2012.
- United Therapeutics Corporation employee service share-based compensation, tax benefit realized from exercise of stock options (deprecated 2017-01-31) for fiscal 2012 was $3.05M, a 73.09% decline from fiscal 2011.
| Period end | Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options (Deprecated 2017-01-31) 12 month |
|---|---|
| 2015-12-31 | $37.43M 10-K · filed 2016-02-25 |
| 2014-12-31 | $30.84M 10-K · filed 2016-02-25 |
| 2013-12-31 | $9.30M 10-K · filed 2016-02-25 |
| 2012-12-31 | $3.05M 10-K · filed 2015-02-24 |
| 2011-12-31 | $11.35M 10-K · filed 2014-02-25 |
| 2010-12-31 | $23.83M 10-K · filed 2013-02-26 |
| 2009-12-31 | $4.41M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |